Your mitochondria — the tiny power plants inside every cell — decay with age. By 70, they’re running at roughly half the efficiency they had at 30. But what if a compound produced naturally by your gut bacteria could trigger your cells to clean out those damaged mitochondria and replace them? That’s the promise of urolithin A, a molecule discovered by researchers including Johan Auwerx at EPFL and tested in human trials by the Swiss biotech company Amazentis (now Timeline Nutrition). It’s one of the few longevity compounds with multiple randomized, placebo-controlled trials published in top-tier journals including Nature Metabolism, JAMA Network Open, and Cell Reports Medicine.
🥇
Evidence Tier: Gold
Multiple double-blind, placebo-controlled human RCTs across diverse populations (middle-aged, older adults, athletes, heart failure patients) with consistent results.
⚖️ At a Glance: Pros & Cons
⚠️ We are researchers, not doctors. Nothing on this page is medical advice. Urolithin A interacts with cellular pathways relevant to aging. Always consult your physician before starting any new supplement — especially if you take medications or have a medical condition.
✅ Pros
Strongest evidence for muscle: Urolithin A improved muscle strength by ~12% and increased aerobic endurance in a 4-month RCT of middle-aged adults (Singh et al., 2022).
Clinically meaningful in older adults: A JAMA-published trial in 65+ year olds showed improvements in 6-minute walk distance and hand/leg muscle endurance over 4 months.
Immune system rejuvenation: A 2025 Nature Aging trial found UA expands T memory stem cells — suggesting it may partially reverse age-related immune decline.
Well-tolerated safety profile: Human trials up to 4 months at 500–1000 mg/day show UA is safe with no serious adverse events attributable to the compound.
❌ Cons
Only works for some people: 30–50% of people lack the gut bacteria needed to produce urolithin A naturally. Supplementation bypasses this, but individual response varies.
Long-term safety unknown: The longest human trial is 4 months. Lifetime mitophagy activation hasn’t been studied — there’s theoretical concern about over-clearing mitochondria.
Expensive: Mitopure (the branded form used in trials) costs ~$100/month. Generic urolithin A is cheaper but quality varies.
Effects may be modest in healthy young people: A trial in young distance runners showed no performance improvement — UA’s benefits appear most pronounced in aging or stressed mitochondria.
What Is Urolithin A?
Urolithin A (UA) is not found in any food. It’s a postbiotic — a compound your gut bacteria produce when they digest ellagitannins, which are polyphenols found in pomegranates, walnuts, raspberries, strawberries, and almonds.
Here’s the catch: you may not be making any urolithin A at all. Whether you can produce it depends on your gut microbiome composition. Researchers classify people into three “metabotypes”:
- Metabotype A (~30–50% of people): Can produce urolithin A from ellagitannins.
- Metabotype B (~10–20%): Produce urolithin B and isourolithin A instead.
- Metabotype 0 (~30–40%): Cannot produce any urolithins at all.
This means that simply eating pomegranates won’t give everyone the benefits. Supplementing with pure urolithin A (like Mitopure) bypasses this gut bottleneck entirely — delivering the active compound regardless of your microbiome.
How It Works: The Mitophagy Connection
Mitochondria are the energy factories of your cells. Over time, they accumulate damage from oxidative stress, producing less energy and leaking harmful molecules. Cells have a quality-control process called mitophagy — a specialized form of autophagy that identifies damaged mitochondria and recycles them.
Mitophagy declines with age. By clearing out dysfunctional mitochondria, cells can be rejuvenated with newer, more efficient power plants. This is where urolithin A comes in:
- UA activates the PINK1/Parkin pathway — the master switch for mitophagy. It triggers Parkin protein to tag damaged mitochondria for recycling.
- UA works through the AMPK-mTOR axis — AMPK is an energy sensor that kickstarts cellular cleanup; mTOR is the growth signal that gets turned down when cleanup is needed.
- UA enhances mitochondrial biogenesis — not only does it clear out the garbage, it signals the cell to build new mitochondria (shown in C2C12 muscle cell studies).
In plain English: urolithin A tells your cells to take out the mitochondrial trash and build new power plants.
The Longevity Connection: What Human Trials Actually Show
🦵 Muscle Strength & Endurance
This is where the evidence is strongest. Three major human RCTs demonstrate consistent muscle benefits:
- Singh et al. (2022) — Cell Reports Medicine: 66 middle-aged adults (average 56 years), 4 months of UA (500mg or 1000mg/day). Muscle strength improved by ~12% in the hamstring. Aerobic endurance (VO₂ max) showed clinically meaningful improvements. Blood biomarkers confirmed mitophagy activation.
- Liu et al. (2022) — JAMA Network Open: 89 older adults (65–90 years), 4 months of UA (1000mg/day). The 6-minute walk distance improved. Hand and leg muscle endurance increased. Plasma acylcarnitines (a marker of mitochondrial inefficiency) dropped — confirming the mechanism.
- 2025 systematic review & meta-analysis: Pooled analysis of all available RCTs confirmed UA significantly improves muscle performance and mitochondrial biomarkers in humans.
🛡️ Immune System Rejuvenation
A 2025 Nature Aging trial tested UA in older adults and found it expanded T memory stem cells — a type of immune cell that declines with age and is critical for responding to new infections. The researchers concluded UA may partially reverse age-related immune decline, a finding that positions it as a potential immune-aging intervention.
🧠 Brain Health (Preclinical, Promising)
Multiple reviews (2026) highlight UA’s ability to cross the blood-brain barrier and activate mitophagy in neurons. Preclinical models of Alzheimer’s and Parkinson’s disease show UA reduces neuroinflammation and preserves cognitive function. No human cognition trials yet — this is “watch this space” territory.
❤️ Heart Function
- Heart failure trial (2024): A small crossover RCT in 10 patients with heart failure with reduced ejection fraction tested UA (500mg twice daily). Results were exploratory but suggested mitochondrial benefits.
- Preclinical HFpEF study (2026): UA ameliorated cardiac remodeling in a mouse model of heart failure with preserved ejection fraction, activating mitophagy via AMPK-mTOR.
Key Studies at a Glance
| Study | Design | Key Finding |
|---|---|---|
| Singh et al. 2022 (Cell Rep Med) | RCT, 66 adults, 4 months | ~12% muscle strength gain; improved VO₂ max; mitophagy biomarkers confirmed |
| Liu et al. 2022 (JAMA Netw Open) | RCT, 89 older adults, 4 months | Better 6-min walk distance; improved muscle endurance; reduced acylcarnitines |
| Andreux et al. 2019 (Nat Metab) | Phase 1, 60 adults, 28 days | First-in-human: safe, well-tolerated, induces mitochondrial gene expression |
| Nature Aging 2025 | RCT, older adults | UA expanded T memory stem cells — potential immune aging reversal |
| 2025 Sports Med (distance runners) | RCT, 42 trained runners | No significant performance improvement in young, healthy athletes |
| 2024 (Rev Recent Clin Trials) | RCT crossover, 10 HFrEF patients | Exploratory mitochondrial benefits in heart failure |
Dosing and Safety
Recommended Protocol
| Parameter | Recommendation |
|---|---|
| Dose | 500–1000 mg/day (human trials used both; 1000mg showed slightly stronger effects) |
| Timing | Take with food (fat-soluble; absorption may improve with a meal) |
| Form | Mitopure (Timeline Nutrition) is the branded form used in most clinical trials. Generic urolithin A is available but quality and absorption may vary. |
| Cycle | No cycling data from human trials. All studies used continuous daily dosing for 4 months. |
| Duration | Benefits observed at 4 months. Longer-term effects unknown. Consider periodic breaks given the lack of multi-year safety data. |
Side Effects
| Side Effect | Frequency | Notes |
|---|---|---|
| Mild GI discomfort | Uncommon | Typically resolves within first week |
| Headache | Rare | Reported in some trials; not clearly UA-attributable |
| Serious adverse events | None reported | No SAEs attributable to UA across all human trials |
Common Questions About Urolithin A
What is Urolithin A and how does it work?
Urolithin A is a compound your gut bacteria produce from foods like pomegranates and walnuts — but only 30-50% of people have the right gut bacteria to make it. It works by triggering mitophagy, which is your cells’ cleanup system for damaged mitochondria. Think of it as taking out the cellular trash so your energy factories run more efficiently.
What does the evidence actually show?
The evidence is strongest for muscle benefits. Two major trials published in Cell Reports Medicine (2022) and JAMA Network Open (2022) found urolithin A improved muscle strength by about 12% and increased walking endurance in middle-aged and older adults. A 2025 Nature Aging trial suggests it may also rejuvenate the aging immune system. Evidence for brain and heart benefits is still preclinical.
What’s the right dose?
Human trials used 500–1000 mg per day, taken with food for better absorption. The 1000 mg dose showed slightly stronger effects in some studies. There’s no evidence that more than 1000 mg provides additional benefit, and the longest trial was 4 months — so long-term optimal dosing isn’t known.
What are the risks and side effects?
Urolithin A is well-tolerated in human studies. Mild digestive discomfort is the most commonly reported side effect, usually resolving within a week. No serious adverse events have been linked to UA in any clinical trial. The main unknown is long-term safety — no one has taken it for more than 4 months in a controlled study.
Who should avoid it?
Pregnant or nursing women should avoid urolithin A — there’s zero safety data in these groups. People with mitochondrial diseases should consult a specialist before using anything that affects mitophagy. If you’re on medications, particularly blood thinners or immunosuppressants, check with your doctor — potential interactions haven’t been studied.
The Bottom Line
Urolithin A is one of the best-studied longevity supplements with human evidence. It has a clear mechanism (mitophagy activation), multiple RCTs in respected journals, and consistent signals for muscle and immune benefits. The evidence hierarchy:
- Strongest: Muscle strength and endurance in middle-aged and older adults (multiple RCTs, consistent results)
- Promising: Immune system rejuvenation (one Nature Aging trial, needs replication)
- Preclinical: Brain and heart benefits (animal/cell models, no human trials yet)
Our verdict: If you’re over 50 and muscle function or mitochondrial health is a priority, urolithin A is worth considering — the human evidence is solid and the safety profile is clean in the short term. The main drawbacks are cost (~$100/month for the branded form) and the unknown of long-term use. Younger, healthy athletes likely won’t benefit — the evidence suggests UA helps stressed or aging mitochondria, not already-optimized ones.
Who it’s for: Adults 50+ concerned about age-related muscle decline; anyone interested in mitochondrial health with the budget to sustain it. Not for: young athletes, pregnant women, or those expecting a dramatic energy boost — UA is about slowing decline, not delivering a buzz.
Medical Disclaimer: This page provides information based on published scientific research. It does not constitute medical advice. Urolithin A is a dietary supplement, not a drug. The FDA has not evaluated these statements. Always consult your physician before starting any new supplement, especially if you have a medical condition, take medications, or are pregnant or nursing.
Sources
- Singh A, et al. Urolithin A improves muscle strength, exercise performance, and biomarkers of mitochondrial health in a randomized trial in middle-aged adults. Cell Reports Medicine. 2022. PMID: 35584623
- Liu S, et al. Effect of Urolithin A Supplementation on Muscle Endurance and Mitochondrial Health in Older Adults: A Randomized Clinical Trial. JAMA Network Open. 2022. PMID: 35050355
- Andreux PA, et al. The mitophagy activator urolithin A is safe and induces a molecular signature of improved mitochondrial and cellular health in humans. Nature Metabolism. 2019. PMID: 32694802
- Effect of the mitophagy inducer urolithin A on age-related immune decline: a randomized, placebo-controlled trial. Nature Aging. 2025. PMID: 41174221
- Effects of Urolithin A supplementation on muscle health outcomes in humans from randomized controlled trials. Frontiers in Nutrition. 2026. PMID: 42559151
- Health Benefits and Molecular Mechanisms of Urolithin A. Food Science & Nutrition. 2026. PMID: 42502809
- The microbiome-mitochondria axis: the context-dependent role of urolithin A in aging and cancer. Molecular Biology Reports. 2026. PMID: 42550351
- Is Urolithin A a pharmacologically credible neuro-nutraceutical? Neurochemistry International. 2026. PMID: 42468665
- Urolithin A activates mitophagy via the AMPK-mTOR axis and modulates the gut-ceramide axis to ameliorate cardiac remodeling in HFpEF. Experimental & Molecular Medicine. 2026. PMID: 42432192
- Assessment of Urolithin A effects on muscle endurance, strength, inflammation in male athletes. JISSN. 2024. PMID: 39487653
- Evaluating the Impact of Urolithin A Supplementation on Running Performance in Highly Trained Male Distance Runners. Sports Medicine. 2025. PMID: 40839339
- Evaluation of Urolithin A Efficacy in Heart Failure Patients with Reduced Ejection Fraction. Reviews on Recent Clinical Trials. 2024. PMID: 38415449